Apoptosis in Cardiac Biology [electronic resource] /

Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.

Saved in:
Bibliographic Details
Main Authors: Schunkert, Heribert. editor., Riegger, G. A. J. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Boston, MA : Springer US, 2000
Subjects:Medicine., Cardiology., Oncology., Medicine & Public Health.,
Online Access:http://dx.doi.org/10.1007/b102337
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:210767
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Cardiology.
Oncology.
Medicine & Public Health.
Cardiology.
Oncology.
Medicine.
Cardiology.
Oncology.
Medicine & Public Health.
Cardiology.
Oncology.
spellingShingle Medicine.
Cardiology.
Oncology.
Medicine & Public Health.
Cardiology.
Oncology.
Medicine.
Cardiology.
Oncology.
Medicine & Public Health.
Cardiology.
Oncology.
Schunkert, Heribert. editor.
Riegger, G. A. J. editor.
SpringerLink (Online service)
Apoptosis in Cardiac Biology [electronic resource] /
description Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.
format Texto
topic_facet Medicine.
Cardiology.
Oncology.
Medicine & Public Health.
Cardiology.
Oncology.
author Schunkert, Heribert. editor.
Riegger, G. A. J. editor.
SpringerLink (Online service)
author_facet Schunkert, Heribert. editor.
Riegger, G. A. J. editor.
SpringerLink (Online service)
author_sort Schunkert, Heribert. editor.
title Apoptosis in Cardiac Biology [electronic resource] /
title_short Apoptosis in Cardiac Biology [electronic resource] /
title_full Apoptosis in Cardiac Biology [electronic resource] /
title_fullStr Apoptosis in Cardiac Biology [electronic resource] /
title_full_unstemmed Apoptosis in Cardiac Biology [electronic resource] /
title_sort apoptosis in cardiac biology [electronic resource] /
publisher Boston, MA : Springer US,
publishDate 2000
url http://dx.doi.org/10.1007/b102337
work_keys_str_mv AT schunkertheriberteditor apoptosisincardiacbiologyelectronicresource
AT rieggergajeditor apoptosisincardiacbiologyelectronicresource
AT springerlinkonlineservice apoptosisincardiacbiologyelectronicresource
_version_ 1756268840649490432
spelling KOHA-OAI-TEST:2107672018-07-30T23:43:09ZApoptosis in Cardiac Biology [electronic resource] / Schunkert, Heribert. editor. Riegger, G. A. J. editor. SpringerLink (Online service) textBoston, MA : Springer US,2000.engApoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.Basic Mechanisms of Apoptosis -- Death receptors and their ligands -- Regulation of apoptosis by CD 137 -- Reactive oxygen species and apoptosis -- Oncogenes and p53 -- BCL-2 family members and mitochondria -- Inhibition of cardiac myocyte apoptosis by gp130-dependent cytokines -- Cell cycle regulation and apoptotic cell death -- Caspase cascades and caspase targets -- Apoptosis: a distinctive form of cell death -- Cellular Targets in the cardiovascular system -- Apoptosis and cell cycle in endothelial cells -- Endurance under stress and cardioprotective functions by cardiac fibroblasts -- Cardiac myocytes -- Cardiac myocytes and fibroblasts exhibit differential sensitivity to apoptosis-inducing stimuli -- Apoptosis in Cardiac Disorders -- Hypertension as a cardiovascular proliverative disorder -- Apoptosis in human atherosclerosis -- Apoptosis in myocardial infarction -- Pro-inflammatory and pro-apoptotic factors in heart failure -- Molecular mechanisms of cardiac myocardial remodeling during aging. Role of apoptosis -- Apoptosis during cardiac surgery -- Therapeutical Options -- New opportunities for heart disease therapeutics -- Beta blocker therapy and prevention of apoptosis -- Apoptosis in cardiac myocytes - Role of the renin-angiotensin-system -- Estrogens and the prevention of cardiac apoptosis -- Open questions on apoptosis in cardiac biology.Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.Medicine.Cardiology.Oncology.Medicine & Public Health.Cardiology.Oncology.Springer eBookshttp://dx.doi.org/10.1007/b102337URN:ISBN:9780585381435